Resource Strategy at Gsk

4133 Words17 Pages
This paper is an analysis of GlaxoSmithKline (GSK) resource strategy; Organising capabilities for innovation and new business”. GSK is a multinational corporation with a diversified product range and is one of the largest drug companies in the world. Sound financial resources, strong sales and marketing, research and development, manufacturing expertise, distribution and logistics are some of the key success factors in the market of pharmaceuticals. These success factors can have both negative and positive implications on large and generic manufacturers which have been discussed in detail in our response to Question One. The authors are of the view that due to its large size, patent drugs, well known brands, niche market and loyal customer base, GSK has competitive advantage. The authors are also of the view that GSK has sustainable competitive advantage due to its continued expansion through acquisitions, joint ventures including continued investment in research and development. The increasing demand of its products and the availability of a niche market also gives the company sustainable competitive advantage. The authors are also of the view that some of the sustainable competitive advantage attributes like availability of niche market, retention of a competent and skilled work force are essential lessons which can be adopted by other companies that may not necessarily be in the pharmaceutical industry. A conclusion summarising all the major talking points is offered at the end of this paper. 1.0 Introduction This paper is a case study analysis of GSK resource strategy; Organising capabilities for innovation and new business”. The paper is divided into five main parts/sections, the introduction and conclusion being the first and last sections of the document respectively. The other three main sections in this paper correspond to the
Open Document